Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, J. W.
Right arrow Articles by Jagust, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. W.
Right arrow Articles by Jagust, W. J.
Related Collections
Right arrow Volumetric MRI
Right arrow Nutritional
Right arrow Alzheimer's disease
Right arrow Risk factors in epidemiology

Neurology 2002;58:1471-1475
© 2002 American Academy of Neurology

Homocysteine, vitamin B6, and vascular disease in AD patients

J. W. Miller, PhD, R. Green, MD, D. M. Mungas, PhD, B. R. Reed, PhD and W. J. Jagust, MD

From the Departments of Medical Pathology (Drs. Miller and Green) and Neurology (Drs. Mungas, Reed, and Jagust), University of California, Davis, School of Medicine, Sacramento.

Address correspondence and reprint requests to Dr. Joshua W. Miller, Department of Medical Pathology, UC Davis Medical Center, Research III, 4645 Second Ave., Rm. 3200A, Sacramento, CA 95817; e-mail: jwmiller{at}ucdavis.edu

Background: Cerebrovascular disease is a cause of dementia and is associated with elevated plasma levels of homocysteine. Patients with AD tend to have unexplained elevations of homocysteine concentrations vs healthy control subjects. Vitamin B6 status, a potential determinant of plasma homocysteine, has not been characterized in patients with AD.

Objective: To investigate plasma homocysteine, vitamin B6 status, and the occurrence of vascular disease in patients with AD.

Methods: Forty-three patients with AD and 37 control subjects without AD were studied for homocysteine, B vitamin status (folate, vitamin B12, pyridoxal-5'-phosphate [PLP]), kidney function (creatinine), and thyroid function (thyroid-stimulating hormone, thyroxin). In addition, the presence of vascular disease was assessed by reviewing both medical histories and brain imaging data provided by CT and MRI.

Results: The OR for elevated plasma homocysteine (>12 µmol/L) was only 2.2 (not significant) for subjects with AD. In contrast, the OR was 10.0 (p = 0.03) for subjects with vascular disease (n = 26). The OR for low plasma PLP (<25 nmol/L) was 12.3 (p = 0.01) for patients with AD. No significant relationship was observed between vascular disease and PLP level or between plasma homocysteine and PLP concentrations.

Conclusions: Elevated plasma homocysteine in patients with AD appears related to vascular disease and not AD pathology. In addition, low vitamin B6 status is prevalent in patients with AD. It remains to be determined if elevated plasma homocysteine or low vitamin B6 status directly influences AD pathogenesis or progression.




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
Y. Lamers, B. O'Rourke, L. R Gilbert, C. Keeling, D. E Matthews, P. W Stacpoole, and J. F Gregory III
Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women
Am. J. Clinical Nutrition, August 1, 2009; 90(2): 336 - 343.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Viswanathan
High-Dose B Vitamin Supplementation as a Disease-Modifying Therapy in Alzheimer Disease
Arch Neurol, April 1, 2009; 66(4): 520 - 522.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
Y. Lamers, J. Williamson, M. Ralat, E. P. Quinlivan, L. R. Gilbert, C. Keeling, R. D. Stevens, C. B. Newgard, P. M. Ueland, K. Meyer, et al.
Moderate Dietary Vitamin B-6 Restriction Raises Plasma Glycine and Cystathionine Concentrations While Minimally Affecting the Rates of Glycine Turnover and Glycine Cleavage in Healthy Men and Women
J. Nutr., March 1, 2009; 139(3): 452 - 460.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
C. Merete, L. M. Falcon, and K. L. Tucker
Vitamin B6 Is Associated with Depressive Symptomatology in Massachusetts Elders
J. Am. Coll. Nutr., June 1, 2008; 27(3): 421 - 427.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. Raman, A. Tatsioni, M. Chung, I. H. Rosenberg, J. Lau, A. H. Lichtenstein, and E. M. Balk
Heterogeneity and Lack of Good Quality Studies Limit Association Between Folate, Vitamins B-6 and B-12, and Cognitive Function
J. Nutr., July 1, 2007; 137(7): 1789 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
E. N. Rowan, H. O. Dickinson, S. Stephens, C. Ballard, R. Kalaria, and R. Anne Kenny
Homocysteine and post-stroke cognitive decline
Age Ageing, May 1, 2007; 36(3): 339 - 343.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
J. A. Luchsinger, M.-X. Tang, J. Miller, R. Green, and R. Mayeux
Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly
Arch Neurol, January 1, 2007; 64(1): 86 - 92.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Regan, C. Katona, Z. Walker, J. Hooper, J. Donovan, and G. Livingston
Relationship of vascular risk to the progression of Alzheimer disease
Neurology, October 24, 2006; 67(8): 1357 - 1362.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
K C Gorson and A H Ropper
Additional causes for distal sensory polyneuropathy in diabetic patients.
J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 354 - 358.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
I. Prohovnik, D. P. Perl, K. L. Davis, L. Libow, G. Lesser, and V. Haroutunian
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Neurology, January 10, 2006; 66(1): 49 - 55.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. C. Irizarry, M. E. Gurol, S. Raju, R. Diaz-Arrastia, J. J. Locascio, M. Tennis, B. T. Hyman, J. H. Growdon, S. M. Greenberg, and T. Bottiglieri
Association of homocysteine with plasma amyloid {beta} protein in aging and neurodegenerative disease
Neurology, November 8, 2005; 65(9): 1402 - 1408.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Porcellini, and F. Licastro
Homocysteine and folate as risk factors for dementia and Alzheimer disease
Am. J. Clinical Nutrition, September 1, 2005; 82(3): 636 - 643.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. L. Boxer, J. H. Kramer, K. Johnston, J. Goldman, R. Finley, and B. L. Miller
Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment
Neurology, April 26, 2005; 64(8): 1431 - 1434.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
K. K. Kharbanda, D. D. Rogers II, M. E. Mailliard, G. L. Siford, A. J. Barak, H. C. Beckenhauer, M. F. Sorrell, and D. J. Tuma
A Comparison of the Effects of Betaine and S-Adenosylmethionine on Ethanol-Induced Changes in Methionine Metabolism and Steatosis in Rat Hepatocytes
J. Nutr., March 1, 2005; 135(3): 519 - 524.
[Abstract] [Full Text] [PDF]

Home page
 J Gerontol A Biol Sci Med SciHome page
A. Garcia, Y. Haron, K. Pulman, L. Hua, and M. Freedman
Increases in Homocysteine Are Related to Worsening of Stroop Scores in Healthy Elderly Persons: A Prospective Follow-Up Study
J Gerontol A Biol Sci Med Sci, December 1, 2004; 59(12): 1323 - 1327.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
A. Garcia and K. Zanibbi
Homocysteine and cognitive function in elderly people
Can. Med. Assoc. J., October 12, 2004; 171(8): 897 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
P. Quadri, C. Fragiacomo, R. Pezzati, E. Zanda, G. Forloni, M. Tettamanti, and U. Lucca
Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 114 - 122.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. A. Luchsinger, M. -X. Tang, S. Shea, J. Miller, R. Green, and R. Mayeux
Plasma homocysteine levels and risk of Alzheimer disease
Neurology, June 8, 2004; 62(11): 1972 - 1976.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
T. Muller, K. Renger, and W. Kuhn
Levodopa-Associated Increase of Homocysteine Levels and Sural Axonal Neurodegeneration
Arch Neurol, May 1, 2004; 61(5): 657 - 660.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. W Miller, R. Green, M. I Ramos, L. H Allen, D. M Mungas, W. J Jagust, and M. N Haan
Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 441 - 447.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. W. Miller, J. Selhub, M. R. Nadeau, C. A. Thomas, R. G. Feldman, and P. A. Wolf
Effect of L-dopa on plasma homocysteine in PD patients: Relationship to B-vitamin status
Neurology, April 8, 2003; 60(7): 1125 - 1129.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. Borroni, C. Agosti, A.F. Panzali, M. Di Luca, A. Padovani, J.W. Miller, R. Green, D.M. Mungas, B.R. Reed, and W.J. Jagust
Homocysteine, vitamin B6, and vascular disease in patients with AD
Neurology, November 12, 2002; 59(9): 1475 - 1476.
[Full Text] [PDF]

Home page
 NeurologyHome page
J. F. Toole and C. R. Jack
Food (and vitamins) for thought
Neurology, May 28, 2002; 58(10): 1449 - 1450.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Homocysteine, vitamin B6, and vascular disease in AD patients
Barbara Borroni, et al.
Neurology Online, 17 Jul 2002 [Full text]
Reply to Letter to the Editor
Joshua W. Miller, et al.
Neurology Online, 17 Jul 2002 [Full text]